Residual OS by EFS12
| Initial management/EFS group . | N (%) . | Event N . | 36 mo OS (95% CI) . | 60 mo OS (95% CI) . | 120 mo OS (95% CI) . | P value∗ . |
|---|---|---|---|---|---|---|
| Active treatment | 19 | <.001 | ||||
| Event-free at 12 mo | 67 (72%) | 100% (100%-100%) | 100% (100%-100%) | 82% (68%-98%) | ||
| Event within 12 mo | 26 (28%) | 73% (58%-92%) | 62% (45%-86%) | 55% (37%-82%) | ||
| Observation | 16 | .9 | ||||
| Event-free at 12 mo | 74 (83%) | 94% (88%-100%) | 88% (79%-97%) | 67% (52%-87%) | ||
| Event within 12 mo | 15 (17%) | 92% (77%-100%) | 92% (77%-100%) | 79% (56%-100%) |
| Initial management/EFS group . | N (%) . | Event N . | 36 mo OS (95% CI) . | 60 mo OS (95% CI) . | 120 mo OS (95% CI) . | P value∗ . |
|---|---|---|---|---|---|---|
| Active treatment | 19 | <.001 | ||||
| Event-free at 12 mo | 67 (72%) | 100% (100%-100%) | 100% (100%-100%) | 82% (68%-98%) | ||
| Event within 12 mo | 26 (28%) | 73% (58%-92%) | 62% (45%-86%) | 55% (37%-82%) | ||
| Observation | 16 | .9 | ||||
| Event-free at 12 mo | 74 (83%) | 94% (88%-100%) | 88% (79%-97%) | 67% (52%-87%) | ||
| Event within 12 mo | 15 (17%) | 92% (77%-100%) | 92% (77%-100%) | 79% (56%-100%) |
The bold values are statistically significant (p values less than 0.05).
Log-rank test.